Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.07%339.181.0%$566.77m
BDXBecton, Dickinson & Co. 2.27%260.111.1%$535.48m
MDTMedtronic Plc 0.36%117.250.6%$516.42m
ISRGIntuitive Surgical, Inc. 0.50%603.362.4%$437.66m
ABTAbbott Laboratories 1.09%89.650.8%$429.80m
DHRDanaher Corp. 1.55%165.950.7%$370.61m
EWEdwards Lifesciences Corp. 1.77%230.541.2%$354.69m
BSXBoston Scientific Corp. 0.26%42.291.1%$346.61m
SYKStryker Corp. 1.92%221.591.3%$338.35m
ALGNAlign Technology, Inc. 0.73%274.956.4%$253.51m
DXCMDexCom, Inc. 12.57%283.918.3%$221.64m
BAXBaxter International, Inc. 0.61%93.131.8%$217.92m
ZBHZimmer Biomet Holdings, Inc. 1.05%160.391.7%$167.56m
TNDMTandem Diabetes Care, Inc. 3.63%86.033.9%$144.59m
ABMDABIOMED, Inc. 1.47%167.223.3%$144.47m

Company Profile

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.